Market Access/ News/ News/ Top stories Bayer completes US filing for prostate cancer drug darolutamide Phil Taylor Bayer, darolutamide, Prostate cancer 0 Comment Bayer has completed its rolling marketing application for prostate cancer drug darolutamide in the US, setting up possible Share X Bayer completes US filing for prostate cancer drug darolutamide https://pharmaphorum.com/news/bayer-completes-us-filing-for-prostate-cancer-drug-darolutamide/
